NURIX THERAPEUTICS INC (NRIX) Top Institutional Shareholders

NURIX THERAPEUTICS INC (NRIX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.75B in NRIX holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of NRIX tracked by InsiderSet, reporting ownership valued at approximately $138.35M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $152.81M, representing an estimated gain of +10.45% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 52% of the total disclosed NRIX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Redmile Group, Llc, Vestal Point Capital, Lp, and several other long-term asset managers with concentrated positions in NURIX THERAPEUTICS INC (NRIX).

This page ranks the largest institutional NRIX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

191

Total Reported Value

$1.75B

Largest Holder

Blackrock, Inc.

Largest Position

$138.35M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

189

Funds Exiting Positions

0

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%8,925,642$138,347,454$152,806,991+$14,459,537+10.45%
Redmile Group, Llc7.94%7,732,808$119,858,524$132,385,673+$12,527,149+10.45%
Vestal Point Capital, Lp2.82%6,500,000$100,750,000$111,280,000+$10,530,000+10.45%
Deep Track Capital, Lp2.03%6,345,244$98,351,282$108,630,577+$10,279,295+10.45%
Fmr Llc0.00%5,541,271$85,889,703$94,866,560+$8,976,857+10.45%
State Street Corp0.00%5,141,195$79,688,523$88,017,258+$8,328,735+10.45%
Morgan Stanley0.00%4,931,999$76,446,010$84,435,823+$7,989,813+10.45%
Baker Bros. Advisors Lp0.41%4,658,556$72,207,618$79,754,479+$7,546,861+10.45%
Vanguard Capital Management Llc0.00%4,427,112$68,620,236$75,792,157+$7,171,921+10.45%
General Atlantic, L.P.2.96%4,101,865$63,578,908$70,223,929+$6,645,021+10.45%
Perceptive Advisors Llc1.14%3,710,877$57,518,594$63,530,214+$6,011,620+10.45%
Pictet Asset Management Holding Sa0.04%2,726,138$42,255,139$46,671,483+$4,416,344+10.45%
Geode Capital Management, Llc0.00%2,520,229$39,070,487$43,146,320+$4,075,833+10.43%
Rubric Capital Management Lp0.47%2,473,885$38,345,218$42,352,911+$4,007,693+10.45%
Deutsche Bank Ag\0.01%2,295,024$35,572,872$39,290,811+$3,717,939+10.45%
Commodore Capital Lp2.04%2,275,000$35,262,500$38,948,000+$3,685,500+10.45%
Braidwell Lp0.91%1,750,766$27,136,873$29,973,114+$2,836,241+10.45%
Trails Edge Capital Partners, Lp6.36%1,743,220$27,019,910$29,843,926+$2,824,016+10.45%
ARK InvestCathie Wood0.21%1,721,135$26,677,596$29,465,831+$2,788,235+10.45%
Longaeva Partners L.P.1.11%1,490,202$23,098,131$25,512,258+$2,414,127+10.45%
Citadel Advisors Llc0.01%1,343,700$20,827,350$23,004,144+$2,176,794+10.45%
Goldman Sachs Group Inc0.00%1,318,659$20,439,215$22,575,442+$2,136,227+10.45%
Eventide Asset Management, Llc0.33%1,297,893$20,117,342$22,219,928+$2,102,586+10.45%
Kynam Capital Management, Lp1.18%1,194,757$18,518,734$20,454,240+$1,935,506+10.45%
Sumitomo Mitsui Trust Group, Inc.0.01%1,181,146$18,307,763$20,221,220+$1,913,457+10.45%
Amova Asset Management Americas, Inc.0.26%1,181,146$18,284,140$20,221,220+$1,937,080+10.59%
Vanguard Portfolio Management Llc0.00%1,102,266$17,085,123$18,870,794+$1,785,671+10.45%
Ubs Group Ag0.00%976,362$15,133,612$16,715,317+$1,581,705+10.45%
Affinity Asset Advisors, Llc0.88%967,620$14,998,110$16,565,654+$1,567,544+10.45%
Soleus Capital Management, L.P.0.59%938,163$14,541,527$16,061,351+$1,519,824+10.45%
Woodline Partners Lp0.05%925,444$14,344,382$15,843,601+$1,499,219+10.45%
Charles Schwab Investment Management Inc0.00%924,039$14,322,605$15,819,548+$1,496,943+10.45%
Capital World Investors0.00%893,327$13,846,569$15,293,758+$1,447,189+10.45%
Northern Trust Corp0.00%854,466$13,244,224$14,628,458+$1,384,234+10.45%
Nuveen, Llc0.00%812,601$12,595,316$13,911,729+$1,316,413+10.45%
Bank Of America Corp0.00%802,153$12,433,372$13,732,859+$1,299,487+10.45%
Dimensional Fund Advisors Lp0.00%780,696$12,094,138$13,365,516+$1,271,378+10.51%
Integral Health Asset Management, Llc0.57%700,000$10,850,000$11,984,000+$1,134,000+10.45%
Vanguard Fiduciary Trust Co0.00%632,231$9,799,581$10,823,795+$1,024,214+10.45%
Jacobs Levy Equity Management, Inc0.04%620,820$9,622,710$10,628,438+$1,005,728+10.45%
Kennedy Capital Management Llc0.18%561,250$8,699,375$9,608,600+$909,225+10.45%
Millennium Management Llc0.01%546,297$8,467,604$9,352,605+$885,001+10.45%
Candriam S.C.A.0.04%534,259$8,281,015$9,146,514+$865,499+10.45%
Qube Research & Technologies Ltd0.01%485,212$7,520,786$8,306,829+$786,043+10.45%
Citigroup Inc0.00%477,410$7,399,855$8,173,259+$773,404+10.45%
Elmind Capital, Lp2.02%460,000$7,130,000$7,875,200+$745,200+10.45%
Point72 Asset Management, L.P.0.01%449,106$6,961,143$7,688,695+$727,552+10.45%
Fisher Asset Management, Llc0.00%384,831$5,964,880$6,588,307+$623,427+10.45%
D. E. Shaw & Co., Inc.0.00%344,203$5,335,147$5,892,755+$557,608+10.45%
Wellington Management Group Llp0.00%321,360$4,981,082$5,501,683+$520,601+10.45%

Frequently asked questions about NRIX

  • Who owns the most NRIX stock?

    The largest holders of NRIX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NURIX THERAPEUTICS INC (NRIX).

  • Is NRIX widely held by superinvestors?

    Many widely followed stocks like NRIX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NRIX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.